· Hospital Donostia, Euskadi
•Primario desconocido
•Tumores indiferenciados
•Utilidad del EMA
•Mama
•S. Nervioso: neurodegenerativas y tumores
•Pulmón/mesotelio
•Piel
•Hígado
•Riñón-urotelio/próstata/testículo
•Ovario/trofoblasto
•Endocrinos-neuroendocrinos
•Partes blandas
•Algoritmo en carcinoma colorectal
•Hematopoyéticos
· HistoPat Laboratoris
•Adenocarcinoma de Origen desconocido (I)
•Adenocarcinoma de Origen desconocido (II)
•Adenocarcinoma vs Carcinoma Escamoso
•Adenocarcinoma vs Mesotelioma
•Linfomas
•Neoplasia Maligna Diferenciada
•Tumores de partes blandas
· Manual of diagnostic antibodies for immunohistology (Leong et al.)
•Bone/soft tissue-chondroid-like tumors
•Brain-metastatic carcinoma vs glioblastoma vs meningioma
•Childhood-round cell tumors
•Gastrointestinal and aerodigestive tract mucosa-basaloid squamous vs adenoid cystic vs neuroendocrine carcinoma
•Gonads-germ cell tumors vs somatic adenocarcinoma
•Granulocytic sarcoma vs lymphoma vs carcinoma
•Intracranial tumors
•Liver-hepatocellular carcinoma vs metastatic carcinoma vs cholangiocarcinoma
•Lung-clear cell tumors
•Lymph node-round cell tumors in adults
•Mediastinal tumors
•Nasal tumors
•Pelvis-metastatic colonic adenocarcinoma vs ovarian endometrioid carcinoma
•Perineum-prostatic vs bladder vs rectal carcinoma
•Peritoneum-myxoid tumors
•Pleura-mesothelioma vs carcinoma
•Retroperitoneum-renal cell carcinoma vs adrenocortical carcinoma vs pheochromocytoma
•Retroperitoneum-vacuolated/clear cell tumor
•Skin-adnexal tumors
•Skin-basal cell carcinoma vs squamous carcinoma vs adnexal carcinoma
•Skin-pagetoid tumors
•Skin-spindle cell tumors
•Soft tissue-epithelioid tumors
•Soft tissue-pleomorphic tumors
•Stomach-undifferentiated spindle cell tumors
•Thyroid carcinomas
•Urinary tract-spindle cell proliferations
•Uterine cervix-endometrial vs endocervical carcinoma
•Uterus-trophoblastic cells
•Uterus-immunophenotyping of syncytiotrophoblast in trophoblastic proliferations
•Tissue-associated antigens in `treatable tumors'
•Epithelial tumors which may coexpress vimentin intermediate filaments
•Mesenchymal tumors which may coexpress cytokeratin
•Tumors which may co-express three or more intermediate filaments
•Primario desconocido
•Tumores indiferenciados
•Utilidad del EMA
•Mama
•S. Nervioso: neurodegenerativas y tumores
•Pulmón/mesotelio
•Piel
•Hígado
•Riñón-urotelio/próstata/testículo
•Ovario/trofoblasto
•Endocrinos-neuroendocrinos
•Partes blandas
•Algoritmo en carcinoma colorectal
•Hematopoyéticos
· HistoPat Laboratoris
•Adenocarcinoma de Origen desconocido (I)
•Adenocarcinoma de Origen desconocido (II)
•Adenocarcinoma vs Carcinoma Escamoso
•Adenocarcinoma vs Mesotelioma
•Linfomas
•Neoplasia Maligna Diferenciada
•Tumores de partes blandas
· Manual of diagnostic antibodies for immunohistology (Leong et al.)
•Bone/soft tissue-chondroid-like tumors
•Brain-metastatic carcinoma vs glioblastoma vs meningioma
•Childhood-round cell tumors
•Gastrointestinal and aerodigestive tract mucosa-basaloid squamous vs adenoid cystic vs neuroendocrine carcinoma
•Gonads-germ cell tumors vs somatic adenocarcinoma
•Granulocytic sarcoma vs lymphoma vs carcinoma
•Intracranial tumors
•Liver-hepatocellular carcinoma vs metastatic carcinoma vs cholangiocarcinoma
•Lung-clear cell tumors
•Lymph node-round cell tumors in adults
•Mediastinal tumors
•Nasal tumors
•Pelvis-metastatic colonic adenocarcinoma vs ovarian endometrioid carcinoma
•Perineum-prostatic vs bladder vs rectal carcinoma
•Peritoneum-myxoid tumors
•Pleura-mesothelioma vs carcinoma
•Retroperitoneum-renal cell carcinoma vs adrenocortical carcinoma vs pheochromocytoma
•Retroperitoneum-vacuolated/clear cell tumor
•Skin-adnexal tumors
•Skin-basal cell carcinoma vs squamous carcinoma vs adnexal carcinoma
•Skin-pagetoid tumors
•Skin-spindle cell tumors
•Soft tissue-epithelioid tumors
•Soft tissue-pleomorphic tumors
•Stomach-undifferentiated spindle cell tumors
•Thyroid carcinomas
•Urinary tract-spindle cell proliferations
•Uterine cervix-endometrial vs endocervical carcinoma
•Uterus-trophoblastic cells
•Uterus-immunophenotyping of syncytiotrophoblast in trophoblastic proliferations
•Tissue-associated antigens in `treatable tumors'
•Epithelial tumors which may coexpress vimentin intermediate filaments
•Mesenchymal tumors which may coexpress cytokeratin
•Tumors which may co-express three or more intermediate filaments
